GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] can we stop arguing about method development until somebody posts a number — 57 comments in the full submission. View in context.
1.8k
c/hplc·submitted 3 months ago by u/teodor_szabo

[Discussion] can we stop arguing about method development until somebody posts a number

Discussionbranch of 6 comments

can we stop arguing about method development until somebody posts a number. I am not trying to be the "source?" guy. I would just like a source. System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the…

Read the full submission and all 57 comments →

This branch

6 comments, started 3 months ago
u/joaquin_petrov276 points·3 months ago

Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.

replysharereportpermalink
u/teodor_szaboOP177 points·3 months ago·edited

baseline choice is a decision, not a measurement

replysharereportpermalink
u/elodie_grimaldi127 points·3 months ago

Is that baseline drawn by the software or by hand?

replysharereportpermalink
u/careful_gradient256 points·3 months ago

Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.

replysharereportpermalink
u/amara_haddad150 points·3 months ago

Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.

Adding one practical thing — run the blank. It answers this before anyone has to argue about it.

replysharereportpermalink
u/sofia_petrescu119 points·3 months ago

Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.

replysharereportpermalink

← back to the whole thread

About c/hplc

The analytical deep end: RP-HPLC methods, gradient design, integration decisions, LC-MS confirmation, amino-acid analysis, water content, and why two labs can report 98.1% and 96.4% on the same vial and both be right. Post the chromatogram, not the summary line.

32kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/hplc rules
  1. Chromatogram or it did not happen. Axis labels included.
  2. State the method: column, gradient, detection wavelength, injection volume.
  3. Area% is not mass%. Posts that conflate them get a correction flair, not a removal.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.